255 related articles for article (PubMed ID: 33595062)
1. Reduction in new cardiac electronic device implantations in Catalonia during COVID-19.
Arbelo E; Angera I; Trucco E; Rivas-Gándara N; Guerra JM; Bisbal F; Jáuregui-Abularach M; Vallés E; Martin G; Sbraga F; Tolosana JM; Linhart M; Francisco-Pascual J; Montiel-Serrano J; Pereferrer D; Menéndez-Ramírez D; Jiménez J; Elamrani A; Borrás R; Dallaglio PD; Benito E; Santos-Ortega A; Rodríguez-Font E; Sarrias A; González-Matos CE; Martí-Almor J; Cabrera S; Mont L
Europace; 2021 Mar; 23(3):456-463. PubMed ID: 33595062
[TBL] [Abstract][Full Text] [Related]
2. Cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy: single center implant data extracted from the Swedish pacemaker and ICD registry.
Valzania C; Gadler F; Boriani G; Rapezzi C; Eriksson MJ
Scand Cardiovasc J; 2020 Aug; 54(4):239-247. PubMed ID: 32054352
[No Abstract] [Full Text] [Related]
3. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on implantation of cardiac implantable electronic devices and remote monitoring activations.
García-Fernández FJ; Calvo Simal S; Cano Pérez Ó; Calvo Cuervo D; Pombo Jiménez M; Fernández Lozano I; Villagraz Tercedor L; Fernández Palacios G; Martín González J
Rev Esp Cardiol (Engl Ed); 2024 Mar; 77(3):243-253. PubMed ID: 37516312
[TBL] [Abstract][Full Text] [Related]
5. Postoperative opioid prescription patterns and new opioid refills following cardiac implantable electronic device procedures.
Lee JZ; Pasha AK; Glasgow AE; Habermann EB; Kusumoto FM; McLeod CJ; Goel V; Sorajja D; Srivathsan K; Shen WK; Madhavan M; Deshmukh AJ; Cha YM; Friedman PA; Asirvatham SJ; Mulpuru SK
Heart Rhythm; 2019 Dec; 16(12):1841-1848. PubMed ID: 31648998
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
[TBL] [Abstract][Full Text] [Related]
7. Cardiac implantable electronic devices procedures and their recipients characteristic during COVID-19 pandemic: 3.8 million population analysis.
Filipecki A; Orszulak M; Tajstra M; Kowalski O; Skrzypek M; Kalarus Z; Gąsior M; Mizia-Stec K
Cardiol J; 2022; 29(1):27-32. PubMed ID: 34931693
[TBL] [Abstract][Full Text] [Related]
8. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of applying a low-dose radiation fluoroscopy protocol in device implantations.
Attanasio P; Mirdamadi M; Wielandts JY; Pieske B; Blaschke F; Boldt LH; Jais P; Haverkamp W; Huemer M
Europace; 2017 Aug; 19(8):1364-1368. PubMed ID: 27702866
[TBL] [Abstract][Full Text] [Related]
10. Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study.
Lee JH; Lee SR; Choi EK; Jeong J; Park HD; You SJ; Lee SS; Oh S
Korean Circ J; 2019 Sep; 49(9):841-852. PubMed ID: 31074230
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 pandemic: Impact on the cardiac implantable electronic devices' implantation rates in Croatia.
Zeljkovic I; Ferri J; Mioc P; Brusich S; Matasic R; Jurisic Z; Szavits Nossan J; Maricic L; Cvitkusic Lukenda K; Radeljic V; Pavlovic N; Manola S
PLoS One; 2023; 18(4):e0284699. PubMed ID: 37099567
[TBL] [Abstract][Full Text] [Related]
12. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
[TBL] [Abstract][Full Text] [Related]
13. Impact of Nationwide COVID-19 Lockdowns on the Implantation Rate of Cardiac Implantable Electronic Devices.
Wood-Kurland HK; Phelps M; Thune JJ; Philbert B; Larroudé CE; Schou M; Hansen ML; Gislason GH; Bang CN
Heart Lung Circ; 2023 Mar; 32(3):364-372. PubMed ID: 36513581
[TBL] [Abstract][Full Text] [Related]
14. The influence of the 2020 COVID-19 pandemic on the implantation rates of cardiac implantable electronic devices in Germany: changes between 2020 Q1-Q3 and 2019 Q1-Q3.
Schwab JO; Wiese J; Hauser T
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):104-112. PubMed ID: 34849668
[TBL] [Abstract][Full Text] [Related]
15. Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases.
Banks H; Torbica A; Valzania C; Varabyova Y; Prevolnik Rupel V; Taylor RS; Hunger T; Walker S; Boriani G; Fattore G;
Europace; 2018 Apr; 20(4):643-653. PubMed ID: 29016747
[TBL] [Abstract][Full Text] [Related]
16. Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases.
Tonegawa-Kuji R; Inoue YY; Nakai M; Kanaoka K; Sumita Y; Miyazaki Y; Wakamiya A; Shimamoto K; Ueda N; Nakajima K; Wada M; Kamakura T; Yamagata K; Ishibashi K; Miyamoto K; Nagase S; Aiba T; Miyamoto Y; Iwanaga Y; Kusano K
BMJ Open; 2023 Jan; 13(1):e068124. PubMed ID: 36639209
[TBL] [Abstract][Full Text] [Related]
17. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
18. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates.
Chui PW; Wang Y; Ranasinghe I; Mitiku TY; Seto AH; Rosman L; Lampert R; Minges KE; Enriquez AD; Curtis JP
Circ Cardiovasc Qual Outcomes; 2019 Jun; 12(6):e005374. PubMed ID: 31185734
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
Traykov V; Bongiorni MG; Boriani G; Burri H; Costa R; Dagres N; Deharo JC; Epstein LM; Erba PA; Snygg-Martin U; Nielsen JC; Poole JE; Saghy L; Starck C; Strathmore N; Blomström-Lundqvist C
Europace; 2019 Aug; 21(8):1270-1279. PubMed ID: 31209483
[TBL] [Abstract][Full Text] [Related]
20. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
